Plain language summary of publication: Comparing nivolumab and neoadjuvant chemotherapy with placebo and neoadjuvant chemotherapy in participants with newly diagnosed estrogen receptor-positive breast cancer in the CheckMate 7FL clinical trial

Loi, S.; Salgado, R.; Curigliano, G.; Iván Romero Díaz, R.; Delaloge, S.; Rojas García, C.I.; Kok, M.; Saura, C.; Harbeck, N.; Mittendorf, E.A.; Yardley, D.A.; Suárez Zaizar, A.; Caminos, F.R.; Ungureanu, A.; Reinoso-Toledo, J.G.; Guarneri, V.; Egle, D.; Ades, F.; Pacius, M.; Chhibber, A.; Chandra, R.; Nathani, R.; Spires, T.; Qun Wu, J.; Pusztai, L.; Mcarthur, H.

doi:10.1080/14796694.2025.2555168

Plain language summary of publication: Comparing nivolumab and neoadjuvant chemotherapy with placebo and neoadjuvant chemotherapy in participants with newly diagnosed estrogen receptor-positive breast cancer in the CheckMate 7FL clinical trial / S. Loi, R. Salgado, G. Curigliano, R. Iván Romero Díaz, S. Delaloge, C.I. Rojas García, M. Kok, C. Saura, N. Harbeck, E.A. Mittendorf, D.A. Yardley, A. Suárez Zaizar, F.R. Caminos, A. Ungureanu, J.G. Reinoso-Toledo, V. Guarneri, D. Egle, F. Ades, M. Pacius, A. Chhibber, R. Chandra, R. Nathani, T. Spires, J. Qun Wu, L. Pusztai, H. Mcarthur. - In: FUTURE ONCOLOGY. - ISSN 1744-8301. - 21:24(2025 Oct), pp. 3091-3101. [10.1080/14796694.2025.2555168]